Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07225595 · ClinicalTrials.gov registry record

Shifting Options Study

A clinical trial of Prenatal Care and Prenatal Diagnosis, sponsored by The Cleveland Clinic.

Active
Registry status
78
Enrollment target
2
Study locations

NCT07225595: Active study of Prenatal Care and Prenatal Diagnosis, sponsored by The Cleveland Clinic.

NCT07225595 is a study of Prenatal Care and Prenatal Diagnosis that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 78 participants, below the 325-participant average among 3 other Prenatal Care trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07225595, a study of Prenatal Care and Prenatal Diagnosis, is active but no longer recruiting, sponsored by The Cleveland Clinic.

ACTIVE NOT RECRUITING
Registry status
78 participants
Enrollment target
2
Study locations

Study Summary

The goal of Shifting Options is to create strategies and resources that will facilitate informed decision-making about prenatal screening and diagnostic testing (PS\&D) for all pregnant patients. Shifting Options will determine how rapid changes in PS\&D and post-diagnosis options affect the nature and timing of resources and support patients need to make informed PS\&D decisions. To achieve this goal, patient participants will be interviewed to identify their PS\&D decision-making needs. Then, clinician participants input will be added on how best to implement strategies that address those needs.

Primary Outcome

The study outcome will include qualitative interview data about the prenatal screening and diagnostic testing decision-making process and a foundation for innovative strategies to support patients' informed decision-making with tandem changes in prenatal genomics and available post-diagnosis options. This work will allow researchers to characterize how patients conceptualize the shifting landscape of testing and post-diagnosis options about prenatal screening and diagnostic testing.

Study Locations (2)

Ohio

  • MetroHealth Medical Center - Cleveland
  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2025-01-01
Est. Completion 2026-06-30
The Cleveland Clinic

688 total trials

What the registry record for NCT07225595 still lists

NCT07225595 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 325-participant average among 3 other Prenatal Care trials with a reported enrollment target (76% lower).

The record links to 2 conditions, with Prenatal Care appearing as the primary indexed condition, and to 0 interventions.

NCT07225595 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT07225595 about?

NCT07225595 is a clinical study titled "Shifting Options Study". The goal of Shifting Options is to create strategies and resources that will facilitate informed decision-making about prenatal screening and diagnostic testing (PS\&D) for all pregnant patients. Shifting Options will determine how rapid changes in PS\&D and post-diagnosis options affect the nature ...

What is the current status of trial NCT07225595?

This trial is currently active not recruiting. The enrollment target is 78 participants. The study started on 2025-01-01. Estimated completion is 2026-06-30.

What conditions does trial NCT07225595 study?

This clinical trial studies the following conditions: Prenatal Care, Prenatal Diagnosis.

Who is sponsoring clinical trial NCT07225595?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07225595 being conducted?

This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prenatal Care

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02397668 · 78 participants · NA

    CorMatrix Cor TRICUSPID ECM Valve Replacement Study

  • NCT03321656 · 78 participants · Phase 2

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

  • NCT03687814 · 78 participants · NA

    Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

  • NCT04018872 · 78 participants · Phase 2

    Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07225595, the US trial registry maintained by the National Library of Medicine. NCT07225595 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.